Carcinoembryonic Antigen Market by F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Etc Key Players Forecasts Till 2023

Pune, India, October 13, 2017/MRFR Press Release/- Market Research Future published a research report on “Carcinoembryonic Antigen Market” - Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2021

The Global Carcinoembryonic Antigen Market report analyze the market According to 2017 studies of NCBI, the Carcinoembryonic Antigen Market report explores burden of colorectal cancer which is projected to increase by 60%, which will lead to 2.2 million new colorectal cancer cases and 1.1 million deaths by 2030. The increased prevalence of colorectal cancer will increase the CEA based diagnostic demands, which will boost the market during the forecast period.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/772 .

Carcinoembryonic antigen or CEA is a group of glycoproteins produced by the gastrointestinal tissues during the fetal development and is involved in cell adhesion. CEA is not present in the healthy adults, however, cancer patients show concentrations of CEA. Colorectal, pancreatic, breast, lung, and other types of cancers can be diagnosed on the basis of the CEA profiling. However, CEA based diagnostic assays are mostly used for the diagnosis of colorectal cancer.

Increasing per capita healthcare expenditure, rising global burden of cancers, and improving medical services will drive the market growth during the assessment period. Risk of haematoma and infections by CEA testing and low healthcare expenditures in developing countries will restrain the market growth during the projected period.

The global carcinoembryonic antigen market is expected to grow 6.7% during the forecast period.

Some of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC.

The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user.

Based on the application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others.

Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others.

Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others.

Get Discount @ https://www.marketresearchfuture.com/check-discount/772 .

Major TOC for Carcinoembryonic Antigen Market:

Research methodology

Market dynamics

Market factor analysis

Global Carcinoembryonic Antigen market, by type

Global Carcinoembryonic Antigen Market, By Type of Content

Global Carcinoembryonic Antigen market, by technology

Global Carcinoembryonic Antigen market, by end user

Global Carcinoembryonic Antigen market, by region

Competitive landscape

...Continued

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: akash.anand@marketresearchfuture.com

This release was published on openPR.